The global bone graft substitute market is experiencing significant growth, driven by various factors such as the increasing incidence of road injuries and joint disorders, the development of biocompatible synthetic bone grafts, and a growing demand for dental bone grafts. Additionally, technological advancements in bone graft substitutes are playing a crucial role in propelling market expansion. The rise in healthcare expenditure globally is another major contributor to the market's growth.
The market is categorized based on product types into allograft, bone graft substitute, and cell-based matrices. Within the allograft segment, further distinctions are made between machined allograft and demineralized bone matrix. The bone graft substitute category is subdivided into bone morphogenic proteins (BMP) and synthetic bone grafts. In 2020, the allograft segment emerged as the dominant force in the market and is anticipated to be the fastest-growing segment moving forward.
A bone graft substitute refers to a synthetic, inorganic, or biologically organic amalgamation used to treat bone defects, providing an alternative to autogenous or allogenous bone. Despite autografts being considered the 'gold standard' for bone grafting, bone graft substitutes have gained popularity among medical practitioners due to the avoidance of the double incision required in autografting procedures, as well as the associated pain during and after surgery at both sites.
The applications of bone graft substitutes are expanding rapidly due to the limitations associated with other bone graft types, including autografts and allografts, such as limited availability, site morbidity, pain, and susceptibility to infections. Notably, demineralized bone matrices (DBM) are employed in approximately 50% of allograft procedures conducted in the United States.
In terms of applications, the global bone graft substitute market is segmented into dental, foot & ankle, joint reconstruction, long bone, and spinal fusion. The spinal fusion segment took the lead in 2020 and is projected to be the fastest-growing segment throughout the study period.
In conclusion, the global bone graft substitute market is witnessing substantial growth propelled by factors like road injuries, joint disorders, advancements in synthetic grafts, and a rising demand for dental bone grafts. The market segmentation based on product types and applications highlights the versatility and expanding applications of bone graft substitutes, positioning it as a preferred option in various medical scenarios. The continuous evolution of technology in this field is expected to sustain the market's growth momentum.
Report Attribute/Metric | Details |
---|---|
Growth Rate | 聽聽9.4% (2023-2032聽聽Base Year聽聽2019聽聽Forecast Period聽聽2020-2027聽聽Historical Data聽聽2018聽聽Forecast Units聽聽Value (USD Million)聽聽Report Coverage聽聽Revenue Forecast, Competitive Landscape, Growth Factors, and Trends聽聽Segments Covered聽聽Product, Material, Application, End user聽聽Geographies Covered聽聽North America, Europe, Asia-Pacific, and Rest of the World (RoW)聽聽Key Vendors聽聽Aesculap Implant System LLp, Integra Lifesciences Corporation, Johnson & Johnson, Kanghui Orthopedic, KLS Martin, MATRIX SURGICAL USA, Medartis AG, Medtronic, OsteoMed, Stryker Corporation, TMJ Concepts, L. Gore and Associates聽聽Key Market Opportunities聽聽New product launches and R&D Amongst major key Players聽聽Key Market Drivers路聽 Increasing participation of key players路聽 Acceptance of craniomaxillofacial (CMF) devices in ambulatory settings路聽 Increasing geriatric population路聽 Untapped emerging markets路聽 Rise in regulatory approvals路聽 Growing demand for bioresorbable devices聽 |
Craniomaxillofacial Devices Market Size was valued at USD 1.88 Billion in 2023. The Global Craniomaxillofacial Devices industry is projected to grow from USD 2.06 Billion in 2024 to USD 4.32 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 10.23% during the forecast period (2024 - 2032).
The increasing participation of key players is one of the key factors driving the craniomaxillofacial (CMF) devices market. In 2019, Kelyniam Global (KLYG) received premarket FDA approval for unique modifications to their PEEK cranio-maxillofacial implant product line.
Various other factors such as the acceptance of craniomaxillofacial (CMF) devices in ambulatory settings, increasing geriatric population, untapped emerging markets, rise in regulatory approvals, and growing demand for bioresorbable devices are also expected to propel the growth of the Craniomaxillofacial (CMF) Devices Market.
However, the low success rate of surgical procedures, and high costs and shortcomings of titanium implants can hamper craniomaxillofacial (CMF) devices market growth over the forecast period.
The craniomaxillofacial devices market is segmented based on product, material, application, end user, and region.
The global craniomaxillofacial (CMF) devices market, by product, is segmented into cranial flap fixation, craniomaxillofacial fixation (CMF) distraction, temporomandibular joint replacement, thoracic fixation, bone graft substitute, CMF plate and screw fixation, and dural repair. The dural repair segment is further classified as dural sealants and dural substitutes.
Based on material, the Craniomaxillofacial (CMF) Devices market is segmented into metals and alloys, bioabsorbable, ceramics, polymers, and others.
Based on application, the Craniomaxillofacial (CMF) Devices market is segmented into neurosurgery, ENT, orthognathic & dental surgery, plastic surgery, and others.
Based on end user, the Craniomaxillofacial (CMF) Devices market is segmented into hospitals, ambulatory surgical centers, and others.
In the current scope of the study, the segments mentioned above are covered into the four global regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and African region.
The craniomaxillofacial devices market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European craniomaxillofacial devices market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The craniomaxillofacial devices market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The craniomaxillofacial devices market in the Middle East & Africa has been segmented into the Middle East and Africa.
Regional Market Summary
The Americas dominated the global market for CMF devices owing to the rising number of craniofacial surgeons within the region. As per the 2017 data published in the Journal of Surgical Education, the number of craniofacial surgery fellowship graduates were increasing. It was reported that around 175 craniofacial surgeons were trained at 35 fellowship programs in 2017. Rising participation of market players is also strongly impacting the growth of the Americas craniomaxillofacial (CMF) devices market. For instance, in 2016, the US- and Brazil-based company, BioArchitects received FDA approval for 3D-printed titanium cranial/maxillofacial implant. This 3D Printing uses electron beam melting technology, which involves using electron beams to melt and fuse very fine metal powder.
In 2018, it was estimated that Europe stood second in the global Craniomaxillofacial (CMF) Devices market. Technological advancements, along with the availability of funding opportunities in research and innovation, will support market growth.
Asia-Pacific (APAC) is expected to represent the phenomenal CMF devices market growth throughout the forecast period due to rising prevalence of chronic conditions, growing awareness about CMF devices, and rising demand for minimally invasive surgeries. The population in developing economies is focusing towards minimally invasive procedures to treat a variety of medical and aesthetic imperfections.
On the other hand, the Middle East and Africa held the least share in the global CMF devices market due to the low economic development, especially within the African region.
Research Methodology
Market Research Future research is conducted by industry experts who offer insights into industry structure, market segmentation, assessment, Competitive Landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research ( 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years by analyzing historical trends and current market positions. Furthermore, the varying trends of segments and categories geographically presented are studied and are estimated based on the primary and secondary research.
Intended Audience
漏 2024 Market Research Future 庐 (Part of WantStats Reasearch And Media Pvt. Ltd.)